RCT Comparing ESWT With PRP for Plantar Fasciitis in High Demand Cohort (NCT02668510) | Clinical Trial Compass
WithdrawnNot Applicable
RCT Comparing ESWT With PRP for Plantar Fasciitis in High Demand Cohort
Stopped: Withdrawn as researcher left before data collection could be completed
United States0Started 2016-01
Plain-language summary
A Randomized Controlled Pilot Trial Comparing Extracorporeal Shock Wave Therapy with Platelet Rich Plasma versus Extracorporeal Shock Wave Therapy in a High Demand Cohort with Resistant Plantar Fasciitis
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* 18 years or older
* Patients that are already selected for ESWT for the treatment of resistant plantar fasciitis as part of clinical care under the doctor-patient relationship
* X-ray imaging studies (Plain radiographs) documenting no additional sources for heel pain within 12 months(all x-rays were conducted as part of standard of care and no radiation will be specific to the research study)
* Active Duty Soldier as they are a high demand cohort with increased frequency of plantar fasciitis compared to the general population as outlined by Scher et al.
* Previously tried conservative management meeting referral to Orthopaedics: Pain medications, taping, orthoses, night splinting or physical therapy
* Body Mass Index (BMI) \<40kg/m2
Exclusion Criteria:
* • History of trauma\* or previous injury to heel requiring operative intervention
* All Soldiers pending medical board evaluation or punitive action
* History of connective tissue disorder (e.g., Marfan's Syndrome, Ehlers-Danlos disease, Rheumatoid Arthritis, etc.)
* Leaving the geographical area permanently or for extended periods of time forcing loss to follow up
* Treatment for plantar fasciitis with injection within the last 6 months
* Surgical indication or internal derangement of the foot
* Chronic pain conditions
* Pregnancy
* Tarsal tunnel syndrome
* Baxter's neuritis
* Rigid flat foot
* Active infection of the Foot overlying the injection area
* Use of immunomodulator…